All In Biotech

Free tool

FAERS Monitor: Divigel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022038 or its brand name (Divigel, Estradiol). Reports on generic versions are filed under their own applications.

Reports

47,535

Serious

22,781

48% of reports

Hospitalization

7,317

Death reported

925

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,941
  • headache2,924
  • fatigue2,903
  • nausea2,901
  • off label use2,436
  • pain2,096
  • diarrhoea1,967
  • dizziness1,746
  • breast cancer female1,709
  • arthralgia1,656
  • pruritus1,576
  • rash1,553
  • dyspnoea1,544
  • product adhesion issue1,539
  • insomnia1,376

Reports by year received

View as table
YearReports
2004525
2005572
2006402
20071,461
2008430
2009600
2010959
2011851
20121,153
2013923
20141,119
20151,927
20162,370
20172,169
20182,525
20192,933
20202,950
20212,889
20223,132
20233,622
20243,717
20255,267
20265,038

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,006,624 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
breast cancer femaleSignal1,70930.228.845,154
product adhesion issueSignal1,53919.918.926,420
insomniaSignal1,3762.32.21,009
headacheSignal2,9242.12.01,655
pruritus1,5761.81.7587
arthralgia1,6561.81.7558
fatigue2,9031.71.6773
nausea2,9011.61.6720
rash1,5531.61.5334
dizziness1,7461.61.5348
pain2,0961.51.4372
diarrhoea1,9671.31.3183
drug ineffective3,9411.31.3332
off label use2,4361.21.2110
dyspnoea1,5441.21.156

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.